Wow, Good job, you got your answer then. Your mission completed, LOL

Good job, you got your answer then. LOL

You can ask Dianne in Investor Relation, do you have her number? LOL

Also you can call in next CC.

You have many choices.

As I said Nasrat will be the ONLY one to decide when is TIME...

Transparency is good but timing is defined by CEO.

You can ask Dianne in IR too!!!

Actually they are working closely with FDA. You know why? FDA requires more opiods with superior ADT on the market. Do you know who has superior ADT technology with many patents??

Thanks Lasers. I mixed these ELI-200 and ELI-201 alot!! LOL


"This is our year"

ELI ADT family! :

ELI-200: Undisclosed Abuse Deterrent opioid (most likely is Morphine/Naltrexone better EMBEDA). BE study done and good result. Even though this was second BE study but will be first NDA to be filed with FDA in 2014. I believe EMBEDA has once-daily and twice-daily, that's why Hakim pushing this first, we will have two version ELI-200 Mor/Nal once-daily and twice-daily. My opinion!

ELI-201: Oxycodone/Naltrexone twice-daily with ART/ADT. BE Study done and good result. Will be filed NDA with FDA in 2014. Three different twice daily formulations developed by Elite were tested in the study. This is generic of OxyContin.

ELI-202: Hydrocodone/Naltrexone twice-daily with ART/ADT.

ELI-216: Oxycodone/Naltrexone once-daily with ART/ADT.

ELI-154: Oxycodone once-daily ER with no ART/ADT , scale up at Elite for a $ 400 million dollar market in Europe.

Well said...."he FDA will be the one's who decide if Elite' ADT is good enough or not. So far the FDA has no complaints."

Lasers, sorry for repeating Pete question again, it says "The ELI-201 pilot study showed that more than one of Elite’s formulations was bioequivalent to the brand product" doesn't that mean ELI-201 (Mor/Nal) has different formulations, I guess we have different size of Naltrexone bead so that's why we have different formulations of ELI-201...the other guess is we have once daily and twice daily EMBEDA and therefore we have once-daily ELI-201 and twice-daily ELI-201...

Any thought?

GLTA

Why you are worried about the result Dr_LOW...?

Nasrat will announce them when is TIME...they said the result is great and superior than many others. We trust Nasrat that says the truth.

Nasrat and his team verify, analyze data and release when is in the benefit of Elite and shareholders.

Nasrat will be the ONLY one to decide when is TIME...

GLTA Longs

Dr J, I understand your frustration but I say be patient. You got in at good time! why worry?! I think your ROI is at least 300% now...

As you know based on Nasrat, Elite will file at least one ADT opiod with FDA this year and it is ELI-200 (undisclosed but most likely better EMBEDA Mor/Nal) and he also said Elite will launch that drug next year 2015.

I trust Nasrat more than ever! He has done many big tasks in last 8 months that he has been in the office.

Long and strong ELITE...

Thanks Lasers, so the rest 63% is owned by independent investors? Any big shareholder in this 63% portion?

Thanks abbey,

Couch, Lasers, NASDAQ2020 any thought plz?

Strategic mistake by potential partner or buy-out...

It would be BIG strategic mistake by potential partner or buy-out company NOT buying Elite at 3 Billion in next 12 months because if Elite launches first ADT (any of ELI-200 or ELI-201 or ELI-202)then the value of Elite would be at least 8 to 10 Billion because roads are paved with proved ADT and FDA and public pushing for ADT opiods...how many ADT Nasrat said we are working on?? was it 15? Are any of those are small opiods..NOOO all are big bucks opiods!!!

Buy in next 12 months in 3 billion OR pay 10 billion in couple years from now....

Go Nasrat!
IMHO

A Question for Couch, Lasers, NASDAQ2020 or any longs:

What percentage of Elite owned by Nasrat Hakim, Elite Directors and Epic combined?

I definitely vote YES, but i above percentage is over 50% then these MM can't change anything here.

Anybody knows what two undisclosed ANDA pending FDA Approval might be?

Undisclosed ANDA pending FDA Approval

I don't agree. we are going up...and don't forget "This is our year"

Glad to see you're back!

This is our year!

"This is our year"

ELI ADT family! :

ELI-200: Undisclosed Abuse Deterrent opioid (most likely is Morphine/Naltrexone better EMBEDA). BE study done and good result. Even though this was second BE study but will be first NDA to be filed with FDA in 2014. I believe EMBEDA has once-daily and twice-daily, that's why Hakim pushing this first, we will have two version ELI-200 Mor/Nal once-daily and twice-daily. My opinion!

ELI-201: Oxycodone/Naltrexone twice-daily with ART/ADT. BE Study done and good result. Will be filed NDA with FDA in 2014. Three different twice daily formulations developed by Elite were tested in the study. This is generic of OxyContin.

ELI-202: Hydrocodone/Naltrexone twice-daily with ART/ADT.

ELI-216: Oxycodone/Naltrexone once-daily with ART/ADT.

ELI-154: Oxycodone once-daily ER with no ART/ADT , scale up at Elite for a $ 400 million dollar market in Europe.



Anyone still interested: YouTube Audio file Elite Conference Call 18-Feb-2014:

"This is our year"

ELITE IR Emails of Today (March 14, 2014) from Dianne:

Email 1:
https://drive.google.com/file/d/0B_KKJc6HS62dSU5vbHRrQ0VaNjQ/edit?usp=sharing


Email 2:
https://drive.google.com/file/d/0B_KKJc6HS62dUG9GSEZKUU9SeDQ/edit?usp=sharing


https://drive.google.com/file/d/0B_KKJc6HS62dbWVEdWdJWEN0czA/edit?usp=sharing


https://drive.google.com/file/d/0B_KKJc6HS62dRWJ6NkxxcXE2bzQ/edit?usp=sharing


https://drive.google.com/file/d/0B_KKJc6HS62dZ2MzS3pUVm9EWjQ/edit?usp=sharing


Email 3:
https://drive.google.com/file/d/0B_KKJc6HS62dMGtXTEMxVmpaMUU/edit?usp=sharing


https://drive.google.com/file/d/0B_KKJc6HS62dU1prWEpBRkN0UG8/edit?usp=sharing


https://drive.google.com/file/d/0B_KKJc6HS62dYjgxZ1FCT3lBbHM/edit?usp=sharing



ELI ADT family! :

ELI-200: Undisclosed Abuse Deterrent opioid (most likely is Morphine/Naltrexone better EMBEDA). BE study done and good result. Even though this was second BE study but will be first NDA to be filed with FDA in 2014. I believe EMBEDA has once-daily and twice-daily, that's why Hakim pushing this first, we will have two version ELI-200 Mor/Nal once-daily and twice-daily. My opinion!

ELI-201: Oxycodone/Naltrexone twice-daily with ART/ADT. BE Study done and good result. Will be filed NDA with FDA in 2014. Three different twice daily formulations developed by Elite were tested in the study. This is generic of OxyContin.

ELI-202: Hydrocodone/Naltrexone twice-daily with ART/ADT.

ELI-216: Oxycodone/Naltrexone once-daily with ART/ADT.

ELI-154: Oxycodone once-daily ER with no ART/ADT , scale up at Elite for a $ 400 million dollar market in Europe.



Anyone still interested: YouTube Audio file Elite Conference Call 18-Feb-2014:

Hey Couch, more I see pressure from public, congress, senate, professionals regarding to why Zohydro has been approved by FDA, proving we have a big treasure in Elite and that's why Nasrat Hakim is pushing to launch 15 ADT asap. GLTA

Sign up here for Elite IR emails:

http://www.elitepharma.com/e_mail_alerts.asp

ELITE IR Emails of Today (March 14, 2014) from Dianne:

Email 1:
https://drive.google.com/file/d/0B_KKJc6HS62dSU5vbHRrQ0VaNjQ/edit?usp=sharing


Email 2:
https://drive.google.com/file/d/0B_KKJc6HS62dUG9GSEZKUU9SeDQ/edit?usp=sharing


https://drive.google.com/file/d/0B_KKJc6HS62dbWVEdWdJWEN0czA/edit?usp=sharing


https://drive.google.com/file/d/0B_KKJc6HS62dRWJ6NkxxcXE2bzQ/edit?usp=sharing


https://drive.google.com/file/d/0B_KKJc6HS62dZ2MzS3pUVm9EWjQ/edit?usp=sharing


Email 3:
https://drive.google.com/file/d/0B_KKJc6HS62dMGtXTEMxVmpaMUU/edit?usp=sharing


https://drive.google.com/file/d/0B_KKJc6HS62dU1prWEpBRkN0UG8/edit?usp=sharing


https://drive.google.com/file/d/0B_KKJc6HS62dYjgxZ1FCT3lBbHM/edit?usp=sharing

wow, I didn't know we have ELI-202 Hydrocodone/Nal.

Lasers, how did you get that?

You're welcome. Totally agreed and as Couch said I think I don't have enough share!! ELTP ha huge potential and as you said the key is patience. Only three more years. I waited here and witnessed it went from 0.04 to 0.97 without having any ART drug in the market, with launching ART drug in next year or so, we will be in another level and Nasdaq..glta

Anyone still interested: YouTube Audio file Elite Conference Call 18-Feb-2014:

You missed the boat long time ago!

Wake up! You got lost in time tunnel...

Totally agreed. GLTA

lol

Why ELI-201 and ELI-200 were first to do BE study?

If you listen to the CC again, Nasrat Hakim said he wants something in his hands then hit the road for partner. He planned to have two different narcotics study, ELI-201 which is Oxycodone and ELI-200 which most likely is Morphine, to show to any interested future partner that Elite technology is plug and play...he has what he wanted, he sounded very passionate and serious...some of us waited here 3 years and now we are 10x of March 2011...I don't mind to wait another 3 years (March 2017) for another 10x (over $6~$7)...GLTA

YouTube Audio file Elite Conference Call 18-Feb-2014:

Thanks NASDAQ2020. ELI-200 / ELI-201 / ELI-216 / ELI-154
Do you agree that ELI-154 won't be marketed in US as per FDA which needs ADT on this type narcotics. But would be a good market in Europe through Nasrat favorite company, right? :)

Here is updated list, hope I have them right...Lasers can you also verify :)

ELI-200: Undisclosed Abuse Deterrent opioid (most likely is Morphine/Naltrexone better EMBEDA). BE study done and good result. Even though this was second BE study but will be first NDA to be filed with FDA in 2014. I believe EMBEDA has once-daily and twice-daily, that's why Hakim pushing this first, we will have two version ELI-200 Mor/Nal once-daily and twice-daily. My opinion!

ELI-201: Oxycodone/Naltrexone twice-daily with ART/ADT. BE Study done and good result. Will be filed NDA with FDA in 2014. Three different twice daily formulations developed by Elite were tested in the study. This generic of OxyContin.

ELI-216: Oxycodone/Naltrexone once-daily with ART/ADT

ELI-154: Oxycodone once-daily ER with no ART/ADT , this might be marketed in Europe, right?

My account still shows over +900 ROI, I was here when it went to 0.25 in 2011(DEM and Danny time!) and then went down to 0.07 and up to 0.15 and down to 0.06

Those have been long here, remembers that Elite board memebers bought at 0.04 at March 2011 and I was a little late and bought at 0.06~0.07! It sucked at the time to buy 50% more expensive than directors! LOL

One thing that I can say patience is a key and do your DD. If you can see POTENTIAL then don't worry about these bumps!

There are a few honest longs here: Couch, Lasers, NASDAQ2020

Bottom line, you need to do your own DD too!

GLTA

Thanks Couch. ELI-200 / ELI-201 / ELI-216 / ELI-154

Here is updated list, hope I have them right...Lasers can you also verify :)

ELI-200: Undisclosed Abuse Deterrent opioid (most likely is Morphine/Naltrexone better EMBEDA). BE study done and good result. Even though this was second BE study but will be first NDA to be filed with FDA in 2014.

ELI-201: Oxycodone/Naltrexone twice-daily with ART/ADT. BE Study done and good result. Will be filed NDA with FDA in 2014. Three different twice daily formulations developed by Elite were tested in the study. This generic of OxyContin.

ELI-216: Oxycodone/Naltrexone once-daily with ART/ADT

ELI-154: Oxycodone twice-daily ER with no ART/ADT , this might be marketed in Europe, right?

Couch, can you help

I'm a little confused here. We had ELI-154 and ELI-216 for years, now we are talking ELI-200 and Eli-201....can you see below and advise if these are correct..can you explain what's difference between Eli-216 and Eli-201.

ELI-200: undisclosed abuse deterrent opioid (My guess is Oxy/Nal better EMBEDA)
ELI-201: 12-Hour Oxycodone/Naltrexone with ART/ADT
ELI-216: 12-Hour Oxycodone/Naltrexone with ART/ADT
ELI-154: 24-hour Oxycodone with no ART/ADT

YouTube Audio file Elite Conference Call 18-Feb-2014 for anyone that missed it.

Couch, got your PM. Sorry didn't know all details, now I know and agreed.

constructive discussion always is ok...why stopping?!!!!

Youtube Audio file Elite Conference Call 18-Feb-2014

Elite Pharma Conference Call 18Feb2014 Audio File [color=red][/color]

https://drive.google.com/file/d/0B_KKJc6HS62dUV8wdWtDSm5jOW8/edit?usp=sharing

You can download and listen entire conference call.

GLTA